One hundred and seventy two (7 %) samples were from patients known to have been recently infected at the time of testing.
116 (4.9% , 95% confidence interval 4.1% to 5.9 %) samples showed medium level resistance and 219 (9.3% , 8.1% to 10.5 %) showed high level resistance to one or more drugs.